Browse > Article

Beneficial effects of body fat and obesity through the inhibition of the digestion of carbohydrate and lipid in gastrointestinal tract  

정은희 (㈜바이오랩 기술연구소)
윤승원 (㈜바이오랩 기술연구소)
이홍석 (㈜바이오랩 기술연구소)
윤유식 (한국 한의학 연구소)
유경미 (서울대학교 생활과학대학 식품영양학과)
황인경 (서울대학교 생활과학대학 식품영양학과)
Publication Information
Korean journal of food and cookery science / v.19, no.1, 2003 , pp. 107-113 More about this Journal
Abstract
In a previous study, a dietary supplement was developed in our lab using natural herbal extracts against digest enzyme activity in GI tract for weight control. This natural herbal extracts could regulate absorption of glucose and lipid by the inhibition of digest enzyme activity. In this study, we screened the natural herbs that inhibit glucoamylase activity and developed an water extract of cinnamon. The cinnamon extract delayed and decreased the increment of carbohydrate degradation through the inhibition of glucoamylase activity in vitro. Fifty volunteers were subjected to the intake of the herbal extracts by taking twice a day for 60 days. As a result, the treated subjects lost 3 kg of body weight and 3.5 kg of body fat mass after the treatment. Furthermore, the body mass index and waist size were significantly decreased during the experimental period. Above results suggested that the administration of the dietary additives composed of cinnamon and natural herbal extract improves the obesity by the decrement of body weight and body fat mass.
Keywords
Obesity; Cinnamon; Body fat mass; Body mass index;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Colditz, GA : Economic costs of obesity. Am. J. Clin. Nutr., 55:503, 1992
2 Beermann, B, Melander, H, Sawe, J, Ulleryd, C and Dahlqvist, R ; Incorrect use and limited weight reduction of orlistat (Xenical) in clinical practice. A cohort study. Eur, J. Clin. Pharmacol., 57(4):309, 2001   DOI   ScienceOn
3 Yoon, YS, Choi, SM, Hong, SB, Hong, JM, Kim, JW, Lee, HS and Hong, SG : Development of an anti-obesity dietary supplement inhibiting the digestion of carbohydrate and lipid, Korean J. Soc. Food Cookery Sci., 18(3):319, 2002
4 Ljung, T, Ahlberg, AC, Holm, G, Friberg, P, Anderson, B, Eriksson, E and Bjorntorp, P : Treatment of abdominally obese men with a serotonin reuptake inhibitoria pilot study. J. Intern. Med., 250(3):219, 2001   DOI   ScienceOn
5 Trichopoulou, A, Gnardellis, C, Benetou, V, Lagiou, P, Bamia, C and Trichopoulos, D : Lipid, Protein and carbohydrate intake in relation to body mass index., Eur. J. Clin. Nutr., 56(1):37, 2002   DOI   ScienceOn
6 Kim, KS, Ezaki, O, Ikemoto, S and Itakura, H : Effects of Platycodon grandiflorum feeding on serum and liver lipid concentrations in rats with diet-induced hyperlipidemia. J. Nutr. Sci. Vitaminol., 41(4):485, 1995   DOI   ScienceOn
7 Hatta, H, Kim, M and Yamamoto, T : A novel isolation method for hen egg yolk antibody, 'IgY', Agric. Biol. Chem., 54, 2531-5, 1990   DOI   ScienceOn
8 Kritchevsky, D, Tepper, SA and Story, JA : Influence of an eggplant (Solanum melongena) preparation on cholesterol metabolism in rats., Exp. Pathol., 10(3-4):180, 1975
9 Higgins, M and D'Agostino, R : Obesity and cardiovascular disease, In Oomura Y.ed. Progress in Obese Research. John Libbey & Comp. Ltd., London, P.381, 1990
10 Hong, SG, Kim, DW, Kim, JW and Lee, HS : Inhibition of carbohydrate digestion using egg yolk antibody, Korean J. Soc. Food Cookery Sci., 18(1):94, 2002
11 Daly, PA and Landsberg, L : Hypertension in obesity and non-insulin-dependent diabetes mellitus. Role of insulin and sympathetic nervous system. Diabetes Care 14:240, 1991   DOI   ScienceOn
12 Sjostrom, LV : Morbidity of severly obese subjects. Am. J. Clin. Nutr., 55:508, 1992
13 Jorge, PA, Neyra, LC, Osaki, RM, Almeida, E and Bragagnolo, N : Effect of eggplant on plasma lipid levels, lipidic peroxidation and reversion of endothelial dysfunction in experimental hypercholesterolemia. Arq. Bras. Cardiol., 70(2):87, 1998   DOI   ScienceOn
14 DeFronzo, RA and Ferrannini, E : Insulin resistance. Amultifaceted syndrome responsible for NIDDM, obestiy. hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173, 1991   DOI   ScienceOn